Design, synthesis, methodology development, and evaluation of PET imaging agents targeting cancer and CNS disorders
Type: article
Abstract: As a non-invasive imaging technique, positron emission tomography (PET) is capable of in vivo quantification of biochemical and pharmacological progress via radiolabeled molecular probes. This dissertation highlights the development of a novel PET radiotracer for imaging -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, 18F labeling methodology for [18F]arylCF2H functionality, and design and synthesis of PET tracers targeting the endocanabinoid system in the brain (i.e. fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL)) and the adenosine A2A receptor (A2AR) in the immune system.
Author: Yuan, Gengyang
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7018376867
